tiprankstipranks
Trending News
More News >
Advertisement

NUKZ - ETF AI Analysis

Compare

Top Page

NUKZ

Range Nuclear Renaissance Index ETF (NUKZ)

Rating:57Neutral
Price Target:
The Range Nuclear Renaissance Index ETF (NUKZ) has a balanced rating, reflecting both strengths and risks within its holdings. Cameco (CCJ) and Hitachi (JP:6501) are standout contributors, with strong financial performance and strategic positioning in the nuclear sector driving positive momentum. However, weaker holdings like AU:SLX, which struggles with declining revenues and persistent losses, may have held back the ETF’s overall rating. Investors should note the ETF’s concentration in the nuclear energy sector, which could amplify risks tied to industry-specific challenges.
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and over the past month, showing positive momentum in its strategy.
Leading Nuclear and Industrial Holdings
Several of the largest positions, including key nuclear and industrial companies, have shown strong performance, helping support the fund’s returns.
Global Exposure Within a Focused Theme
Holdings spread across the U.S., Canada, Japan, the UK, and other markets provide some geographic diversification while still targeting the nuclear renaissance theme.
Negative Factors
High Expense Ratio
The fund charges a relatively high fee, which can eat into long-term returns compared with lower-cost ETFs.
Sector Concentration Risk
Heavy weighting in industrials, utilities, and energy means the ETF is vulnerable if these sectors face a downturn.
Not All Top Holdings Are Performing Well
At least one major holding has shown weak performance this year, which can drag on the fund despite strength in other stocks.

NUKZ vs. SPDR S&P 500 ETF (SPY)

NUKZ Summary

Range Nuclear Renaissance Index ETF (NUKZ) is an exchange-traded fund that follows the VettaFi Nuclear Renaissance Index, focusing on the theme of nuclear energy. It holds companies involved in uranium mining, nuclear reactors, and related technology, with major positions in well-known names like Constellation Energy and Lockheed Martin. Investors might consider NUKZ if they want targeted exposure to the potential long-term growth of nuclear power and to diversify within the clean energy space. A key risk is that it is heavily concentrated in one sector, so its price can swing more than the overall stock market.
How much will it cost me?The Range Nuclear Renaissance Index ETF (NUKZ) has an expense ratio of 0.85%, meaning you’ll pay $8.50 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on a specialized sector like nuclear energy, which requires more research and expertise to select investments.
What would affect this ETF?The Range Nuclear Renaissance Index ETF (NUKZ) could benefit from growing global demand for clean energy and advancements in nuclear technology, as governments and industries prioritize decarbonization. However, it may face challenges from regulatory hurdles, public concerns about nuclear safety, and competition from other renewable energy sources. Its global exposure and focus on sectors like Industrials and Utilities position it well for long-term growth, but economic conditions and geopolitical risks could impact its top holdings and overall performance.

NUKZ Top 10 Holdings

NUKZ is riding the nuclear revival with Cameco in the driver’s seat, as the uranium giant’s rising share price gives the fund much of its spark. Industrial names like Lockheed Martin, Curtiss-Wright, and Hitachi are also climbing steadily, reinforcing the ETF’s tilt toward nuclear hardware, engineering, and defense-related technology. On the flip side, Constellation Energy has been lagging, acting as a bit of a brake on returns, while Oklo’s story remains mixed. Overall, this is a globally focused, nuclear-centric portfolio, but heavily anchored in industrials and utilities.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Cameco11.72%$100.02MC$79.10B165.74%
71
Outperform
Constellation Energy Corporation6.31%$53.87M$89.92B-1.35%
68
Neutral
Lockheed Martin3.22%$27.43M$138.21B35.43%
70
Outperform
GE Vernova Inc.2.94%$25.08M$193.07B85.82%
69
Neutral
Silex Systems Limited2.90%$24.76MAU$2.13B48.00%
44
Neutral
Curtiss-Wright2.87%$24.45M$24.50B91.58%
74
Outperform
Quanta Services2.82%$24.02M$71.77B55.61%
78
Outperform
Oklo Inc2.80%$23.86M$14.75B125.22%
42
Neutral
Rolls-Royce Holdings2.76%$23.52M£101.90B126.55%
71
Outperform
Hitachi,Ltd.2.65%$22.62M¥23.24T47.92%
77
Outperform

NUKZ Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
66.50
Positive
100DMA
66.65
Positive
200DMA
59.44
Positive
Market Momentum
MACD
1.56
Negative
RSI
64.68
Neutral
STOCH
83.49
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NUKZ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 69.35, equal to the 50-day MA of 66.50, and equal to the 200-day MA of 59.44, indicating a bullish trend. The MACD of 1.56 indicates Negative momentum. The RSI at 64.68 is Neutral, neither overbought nor oversold. The STOCH value of 83.49 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NUKZ.

NUKZ Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$839.40M0.85%
$935.78M0.51%
$814.98M0.47%
$764.65M0.64%
$710.44M0.65%
$705.44M0.40%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NUKZ
Range Nuclear Renaissance Index ETF
72.07
24.87
52.69%
BUG
Global X Cybersecurity Etf
IHAK
iShares Cybersecurity & Tech ETF
PBW
Invesco WilderHill Clean Energy ETF
ROBT
First Trust Nasdaq Artificial Intelligence & Robotics ETF
GII
SPDR S&P Global Infrastructure ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement